CALADRIUS BIOSCIENCES, INC.

AMORCYTE

Biological tissue, namely, stem/progenitor cells for the treatment of various cardiovascular diseases;Research and development services regarding the use of stem/progenitor cells for the treatment of various cardiovascular diseases;

ATHELOS

Biotechnology research and development; pharmaceutical drug development; advisory services in connection with the aforementioned;

CALADRIUS

Pharmaceutical products and preparations in the fields of cardiology, vascular diseases, ischemic disorders;

CALADRIUS

Contract manufacturing in the fields of biologics and pharmaceuticals;Regulatory compliance consulting in the field of biologics and pharmaceuticals;Providing medical and pharmaceutical information; adult stem cell banking;Research and development in the pharmaceutical and biotechnology fields; advisory services relating to research and development in the pharmaceutical and biotechnology fields;

CSC

CALIFORNIA STEM CELL;Providing medical information to patients, scientists, physicians and other health care providers;

LISATA

Pharmaceutical preparations; Pharmaceutical preparations for use in treating and managing diseases, disorders, and conditions involving oncology, cardiology, vascular system, and ischemia; Therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for promoting ischematic repair, regenerating damaged tissue, stimulating the repair or growth of microvasculature, penetrating tissue surrounding tumors, and altering immunosuppressive tumor microenvironments;Research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia; Providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia Drug discovery services;

MOTORBLAST

MOTOR BLAST;Stem cell growth media for laboratory testing or research;

MOTORGRAFT

Pharmaceutical products for treatment of the nervous system of the human body; cells for medical or clinical use; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery products in the nature of pharmaceutical preparations for the treatment of motor neuron disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins, enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders; human motor neurons for medical use, namely, replacing endogenous motor neurons; instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of motor neuron disease, single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization;MOTOR GRAFT;

NEOSTEM

Contract manufacturing in the field of biologics and pharmaceuticals;Biotechnology research and development; pharmaceutical drug development; advisory services in connection with the aforementioned;

NEUROBLAST

Stem cell growth media for laboratory testing or research;

PROVOQUE

Non-medicated skin care preparations;The English translation of PROVOQUE in the mark is PROVOKE.;

STEMBLAST

STEM BLAST;Stem cell growth media for laboratory testing or research;